Login / Signup

Illuminating the landscape of high-level clinical trial opportunities in the All of Us Research Program.

Cathy WangLina SuliemanPaul A Harris
Published in: Journal of the American Medical Informatics Association : JAMIA (2024)
All of Us data are a valuable resource for identifying trial opportunities to inform trial portfolio planning. Characterizing these opportunities with consideration for SDoH can provide guidance on prioritizing the most pressing barriers to trial participation.
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • randomized controlled trial
  • double blind
  • quality improvement
  • big data
  • placebo controlled